跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 采薇
教授
,
護理學系
合聘教授
,
國際高齡健康暨長期照護博士學位學程
成員
,
臺北醫學大學考科藍臺灣研究中心
成員
,
臺北醫學大學生醫器材研究中心
https://orcid.org/0000-0002-6722-1153
電子郵件
tsaiwei
tmu.edu
tw
h-index
1069
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2025
每年研究成果
概覽
指紋
網路
專案
(22)
研究成果
(117)
資料集
(6)
類似的個人檔案
(6)
指紋
查看啟用 Tsai-Wei Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Meta Analysis
96%
Malignant Neoplasm
60%
Systematic Review
47%
Quality of Life
27%
Symptom
27%
Palliative Therapy
22%
Confidence Interval
20%
Virtual Reality
20%
Practice Guideline
18%
Parkinson's Disease
16%
Cross-Sectional Study
14%
Breast Cancer
13%
Disease
13%
Hospice Care
13%
Medline
12%
Self-Efficacy
12%
Liver Cell Carcinoma
12%
Cochrane Library
11%
Nursing Student
10%
Literature Review
10%
Oncology Nurse
10%
Cancer Therapy
9%
Oral Mucositis
8%
Embase
8%
Heart Rate Variability
8%
Advanced Cancer
8%
Phototherapy
8%
Cryotherapy
8%
Auriculotherapy
8%
Health Care Personnel
7%
Postoperative Pain
7%
Prevalence
7%
Ward
6%
Dyspnea
6%
Odds Ratio
6%
Radiofrequency Ablation
6%
Shared Decision-Making
5%
Analgesia
5%
Vital Sign
5%
Radiotherapy
5%
Adverse Event
5%
Sleep Disorder
5%
Clinical Guideline
5%
Compression Therapy
5%
Varicosis
5%
Vein Surgery
5%
Medicine and Dentistry
Meta-Analysis
100%
Randomized Controlled Trial
81%
Systematic Review
52%
Malignant Neoplasm
23%
Breast Cancer
18%
Cancer-Related Fatigue
16%
Symptom
15%
Parkinson's Disease
12%
Head and Neck Cancer
12%
Quality of Life
11%
Postoperative Pain
10%
Trismus
8%
Breast Cancer-Related Lymphedema
8%
Auriculotherapy
8%
Heart Rate Variability
8%
Pulse Rate
8%
Radiofrequency Ablation
8%
Hepatocellular Carcinoma
8%
Disease
7%
Arm
7%
Vital Sign
6%
Effect Size
6%
Dyspnea
6%
Great Saphenous Vein
6%
Self Concept
6%
Systolic Blood Pressure
6%
Clinician
5%
Random Effects Model
5%
Cancer Therapy
5%
Survival Rate
5%
Diastolic Blood Pressure
5%
Overall Survival
5%
Adverse Event
5%
Symptomatic Treatment
5%
Compression Therapy
5%
Vein Surgery
5%
Varices
5%
Leg
5%
Recurrence Risk
5%
Disease Free Survival
5%
Analgesia
5%
Outpatient
5%
Oncology
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
62%
Malignant Neoplasm
50%
Oral Mucositis
14%
Parkinson's Disease
12%
Chemotherapy
12%
Symptom
9%
Trismus
8%
Probiotic Agent
8%
Head and Neck Cancer
8%
Mucosa Inflammation
8%
Breast Cancer
8%
Liver Cell Carcinoma
8%
Survival Rate
7%
Overall Survival
6%
Adverse Event
6%
Recurrent Disease
6%
Clinical Trial
5%
Disease
5%
